跳至主要内容
临床试验/CTRI/2021/04/033080
CTRI/2021/04/033080招募中3 期

INTERNATIONAL VALIDATION STUDY OF SENTINEL NODE BIOPSY IN EARLY CERVICAL CANCER - SENTICOL III

Centre Hospitalier Universitaire de Besanon0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient must be ââ?°Â¥ 18 years old.
  • 2. With squamous or adenocarcinoma of the cervix (proven by biopsy or cone biopsy)
  • 3. Stage Ia1 with lymphovascular emboli, Ia2, Ib1, Ib2 and IIa1, (clinical stage) of the 2018 FIGO
  • classification.
  • 4. Maximum diameter ââ?°Â¤ 40 mm by clinical examination and/or magnetic resonance imaging (MRI)
  • 5. No suspicious on pelvic MRI with an exploration up to the left renal vein
  • 6. ECOG performance status 0-2
  • 7. Signed informed consent and ability to comply with follow-up

排除标准

  • 1. Pregnancy,
  • 2. Previous pelvic or abdominal cancer,
  • 3. Previous chemotherapy and/or radiation therapy for cervical cancer
  • (previous brachytherapy is accepted),
  • 4. Proven allergy to blue dye, isotope or indocyanine green (ICG)
  • 5.Other malignancy within the last 5 years except for treated cancer-free of disease and treatment,
  • 6.Patients with synchronous cancer

研究者

发起方
Centre Hospitalier Universitaire de Besanon

相似试验

INTERNATIONAL VALIDATION STUDY OF SENTINEL NODE... | 临床试验